Insider filing · GILD
Merdad Parsey
Chief Medical Officer
profile →
Gilead Sciences, Inc.
GILD · Healthcare · 86 filings in 24 months
ticker →
Merdad Parsey sold $2.3M of Gilead Sciences (GILD)
Executed Nov 6 2024, disclosed Nov 7 2024, 1 day later.
Value, as filed
$2.3M
25,590 sh across 2 lots
Executed
Nov 6 2024
the trade date, as filed
Disclosed
Nov 7 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MPMerdad Parsey (Chief Medical Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $15.1M of GILD (164,211 sh across 5 lots, as filed), executed Nov 27 2024.
The name
GILDHealthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Merdad Parsey in GILD
GILDSALE
Gilead Sciences, Inc.
$15.1M164,211 sh across 5 lots
Exec Nov 27 2024
Filed Nov 29 2024 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $168K
2,000 sh × $83.83
Exec Oct 1 2024
Filed Oct 2 2024 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $1.8M
21,246 sh × $84.50
Exec Sep 12 2024
Filed Sep 13 2024 · 5:30 PM ET